Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2193 Results for "
Growth factor
" in MedChemExpress (MCE) Product Catalog:
Products (2193)
2193 Results for "Growth factor" in MCE Product Catalog:
12
12 Cited Publications
Synonyms: T-DXd; DS-8201; DS-8201a
Target:
Research Areas:
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
12
Target:
Research Areas:
Cardiovascular Disease Neurological Disease Inflammation/Immunology
Alvelestat (AZD9668) is an orally active, selective inhibitor of neutrophil elastase. Alvelestat reduces elastase activity, myeloperoxidase release, neutrophil recruitment and activation, and calcium phosphate precipitation; promotes smooth muscle cell colonization and collagen deposition; and inhibits the formation of neutrophil extracellular traps (NETs) as well as NET-derived neutrophil elastase activity. Alvelestat restores endothelial dysfunction, regulates antioxidant factors, improves the expression of endothelial tight junctions, reduces vascular leakage, and accelerates wound healing. Alvelestat prevents pulmonary hemorrhage, matrix protein degradation, airspace enlargement, and small airway wall remodeling; and alleviates cigarette-induced inflammatory responses. Alvelestat inhibits the growth of abdominal aortic aneurysms exacerbated by Porphyromonas gingivalis. Alvelestat can be used in research related to chronic obstructive pulmonary disease, abdominal aortic aneurysm, radiation-induced skin injury, and bronchiectasis .
11
11 Cited Publications
Synonyms: RC-1291; ONO-7643
Target:
Research Areas:
Anamorelin (RC-1291) is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin can be used in the research of anorexia and cancer cachexia .
11
11 Cited Publications
Synonyms: RC-1291 hydrochloride; ONO-7643 hydrochloride
Target:
Research Areas:
Anamorelin (RC-1291) hydrochloride is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin hydrochloride can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin hydrochloride can be used in the research of anorexia and cancer cachexia .
11
11 Cited Publications
BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU9931 has significant antitumor activity .
10
10 Cited Publications
Cat. No.: HY-P7331
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FGF2; BFGF; Prev. FGFB; Basic Fibroblast Growth factor; Fibroblast Growth factor 2 (Basic); Fibroblast Growth factor; Heparin-Binding Growth factor 2; Prostatropin; HBGF-2; FGF2A; FGF-2; FGF; Fibroblast Growth factor 2; Basic Fibroblast Growth factor BFGF
Species:
Human
Source:
E. coli
10
10 Cited Publications
Cat. No.: HY-P7087
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PDGFB; Platelet-Derived Growth factor 2; Prev. SIS; PDGF Subunit B; Platelet-Derived Growth factor Beta Polypeptide; PDGF2; Platelet-Derived Growth factor Subunit B; Platelet-Derived Growth factor, Beta Polypeptide (Oncogene SIS); Platelet-Derived Growth
Species:
Mouse
Source:
E. coli
10
10 Cited Publications
Cat. No.: HY-P7120
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB3; Transforming Growth factor, Beta 3; Prev. ARVD1; Transforming Growth factor Beta; Prev. ARVD; TGF-Beta3; Transforming Growth factor Beta-3 Proprotein; LDS5; Prepro-Transforming Growth factor Beta-3; RNHF; Arrhythmogenic Right Ventricular Dysplasia
Species:
Human
Source:
HEK293
10
10 Cited Publications
Synonyms: AV-951; KRN951
Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor efficacy .
10
10 Cited Publications
Synonyms: AV-951 hydrochloride hydrate; KRN951 hydrochloride hydrate
Tivozanib hydrochloride hydrate is the hydrate hydrochloride form of Tivozanib (HY-10977). Tivozanib hydrochloride hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrochloride hydrate exhibits antitumor efficacy .
10
10 Cited Publications
Synonyms: AV-951 hydrate; KRN951 hydrate
Tivozanib hydrate (AV-951 hydrate; KRN951 hydrate) is the hydrate form of Tivozanib (HY-10977). Tivozanib hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrate exhibits antitumor efficacy .
9
9 Cited Publications
Cat. No.: HY-P7312
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular Endothelial Growth factor A; VEGF; VPF; Vascular Permeability factor; Vascular Endothelial Growth factor A, Long Form; VEGF-A; L-VEGF; Vascular Endothelial Growth factor A121; Vascular Endothelial Growth factor A165; Vascular Endothelial G
Species:
Mouse
Source:
E. coli
9
9 Cited Publications
Cat. No.: HY-P2093
CAS No.: 1083433-49-1
Target:
Research Areas:
9
9 Cited Publications
Cat. No.: HY-P2093B
Target:
Research Areas:
9
8
Target:
Parbendazole (SKF‑29044) is an orally active benzimidazole carbamate compound with multiple biological activities. Parbendazole binds to free tubulin and inhibits microtubule polymerization; it also activates the JNK/c‑Jun signaling axis and upregulates the expression of the downstream axonal repulsion factor Sema3A. Parbendazole upregulates KAL-1 mRNA expression, reduces nerve growth factor levels, and promotes the terminal differentiation of normal human epidermal keratinocytes. Parbendazole induces apoptosis in differentiated acute myeloid leukemia monocytes and exerts antileukemic activity in a mouse xenograft model of acute myeloid leukemia. Parbendazole exhibits broad-spectrum anthelmintic activity against various animal nematodes. Parbendazole is used in research related to acute myeloid leukemia and parasitic infections .
8
Research Areas:
Lysozyme (Muramidase) is a conserved antimicrobial protein. Lysozyme exerts its bactericidal effect by hydrolyzing bacterial cell wall peptidoglycan (PG). Lysozyme plays an important role in limiting bacterial growth on mucosal surfaces and other sites, not only controlling potential pathogens but also limiting overgrowth of microbiota to prevent dysbiosis. Extracellular lysozyme can also degrade polymeric PG into soluble fragments, activate NOD receptors in mucosal epithelial cells, and lead to the secretion of chemokines and activating factors by neutrophils and macrophages .
7
7 Cited Publications
Cat. No.: HY-P78168
Purity: ≥ 90%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth factor Beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-Beta-1; CED; TGF-Beta1; Transforming Growth factor Beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth factor Beta-1;
Species:
Human
Source:
HEK293
7
7 Cited Publications
iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice .
7
7 Cited Publications
Target:
Research Areas:
GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
